Max Hodak: Average Is Not Good Enough
Science CEO Max Hodak's retinal prosthesis completed clinical trials, restoring vision to blind patients.
“amateurs talk strategy, professionals talk logistics”
Max Hodak, CEO of Science and former Neuralink co-founder, presents at YC Startup School about his company's retinal prosthesis implant that completed major clinical trials. The talk pivots quickly to startup infrastructure and logistics lessons rather than AI or neurotechnology insights. Minimal AI industry signal; content is biomedical and general startup advice.